The New Medicare Part D Out-of-Pocket Cap: What It Means in 2026
How the Medicare Part D out-of-pocket cap works in 2026, with the limit rising to $2,100, the Medicare Prescription Payment Plan, who benefits most, and how Extra Help and the donut hole elimination interact with the new cap.
For decades, Medicare beneficiaries who relied on Medicare Part D prescription drug coverage faced a troubling reality: there was no true limit on how much they could spend out of pocket on medications each year. A beneficiary taking a single specialty drug for cancer or rheumatoid arthritis could easily spend $10,000 or more annually, even after reaching catastrophic coverage. The old 5% coinsurance in the catastrophic phase had no ceiling, and the financial exposure was unlimited.
The Inflation Reduction Act changed that. Beginning January 1, 2025, Medicare Part D introduced a hard annual cap on out-of-pocket prescription drug spending — initially set at $2,000. For 2026, that cap has been adjusted upward to $2,100. This single policy change is the most significant financial protection ever added to Part D, and it affects every person enrolled in a Medicare prescription drug plan.
This guide explains exactly how the out-of-pocket cap works, why it increased to $2,100, how to use the Medicare Prescription Payment Plan to spread your costs into monthly installments, who benefits the most, and how the cap interacts with the donut hole elimination and Extra Help. If you take any prescription medications covered under Part D, this information is essential for managing your healthcare budget in 2026.
What Is the Medicare Part D Out-of-Pocket Cap?
The out-of-pocket cap is a hard annual limit on the total amount you can be required to pay for covered Part D prescription drugs in a calendar year. Once your true out-of-pocket spending reaches the cap, you pay $0 for all covered prescriptions for the remainder of that year. The cap resets on January 1.
For 2026, the cap is $2,100, up from the initial $2,000 that was set for 2025. This adjustment reflects the annual growth rate in per capita Part D drug spending, as specified by the Inflation Reduction Act. CMS announces the updated cap amount each fall along with other Medicare cost figures for the upcoming year.
Before this cap existed, Part D had no maximum out-of-pocket limit. Even in the catastrophic coverage phase — the final phase of the Part D benefit — beneficiaries owed 5% coinsurance on every prescription indefinitely. For someone taking a specialty medication that costs $10,000 per month, that 5% meant $500 per month with no end in sight. The Inflation Reduction Act eliminated that 5% coinsurance entirely, replacing it with $0 cost-sharing once the cap is reached.
Why the Cap Increased from $2,000 to $2,100 in 2026
The Inflation Reduction Act did not set the out-of-pocket cap as a permanent fixed dollar amount. Instead, it established $2,000 as the starting cap for 2025 and directed CMS to adjust it annually based on the rate of growth in per capita Part D spending. This adjustment mechanism ensures the cap keeps pace with rising drug costs over time while still providing meaningful protection.
For 2026, CMS determined that the per capita spending growth rate warranted an increase to $2,100. While any increase may feel unwelcome, it is important to put this in context. The $100 increase represents a 5% adjustment — far smaller than the annual increases in drug list prices that many beneficiaries experienced before the IRA. And compared to the unlimited exposure that existed before 2025, a guaranteed maximum of $2,100 is a transformative protection. A beneficiary who would have spent $8,000 under the old system now spends no more than $2,100.
How the Out-of-Pocket Cap Works: Step by Step
To understand how the cap works, you need to understand how Part D coverage is structured. Medicare is divided into four parts, and Part D covers prescription drugs through a phased benefit design. Your out-of-pocket spending accumulates as you move through these phases during the calendar year.
Phase 1: Annual Deductible
At the start of each year, you pay the full cost of your prescriptions until you meet your plan's annual deductible. For 2026, the maximum Part D deductible is $590. Many plans set a lower deductible, and some waive it entirely for generic drugs. Every dollar you pay during this phase counts toward your $2,100 out-of-pocket cap.
Phase 2: Initial Coverage
After meeting the deductible, you enter initial coverage where you pay a copay or coinsurance for each prescription. Your plan pays the rest. Drug costs are tiered — generics carry lower copays, while brand-name and specialty drugs typically require higher coinsurance. The copays and coinsurance you pay during this phase count toward the $2,100 cap. Initial coverage continues until total drug costs (what you and your plan pay combined) reach $5,030.
Phase 3: Coverage Gap (Donut Hole)
Once total drug costs exceed $5,030, you enter the coverage gap, also known as the donut hole. Thanks to the Inflation Reduction Act, you now pay the same copays and coinsurance in the gap as you did during initial coverage. Drug manufacturers provide discounts on brand-name drugs, and your plan covers additional costs — but you notice no change at the pharmacy counter. Your cost-sharing during this phase also counts toward the $2,100 cap.
Phase 4: Catastrophic Coverage — $0 Cost-Sharing
Once your true out-of-pocket spending reaches $2,100, you enter catastrophic coverage and pay $0 for all covered Part D drugs for the remainder of the calendar year. This is the cap in action. Under the old rules, you would have owed 5% coinsurance in this phase indefinitely. Now you owe nothing.
What Counts Toward the Cap — and What Does Not
Not every dollar you spend on healthcare counts toward the $2,100 cap. Understanding what qualifies is essential to tracking your progress accurately.
Spending that counts toward the cap:
- Your annual Part D deductible payments
- Copayments you make for covered drugs at the pharmacy
- Coinsurance you pay for covered drugs
- Manufacturer discounts on brand-name drugs in the coverage gap (these count toward your total even though you do not pay them directly)
Spending that does not count toward the cap:
- Monthly Part D premiums
- The Part D late enrollment penalty
- Payments for drugs not on your plan's formulary
- Costs for prescriptions filled at out-of-network pharmacies (unless your plan allows out-of-network fills)
- Payments made by other insurance, such as employer coverage or Medicaid
Your Part D plan tracks your out-of-pocket spending automatically. You can check your progress toward the cap by logging into your plan's member portal, calling your plan's customer service number, or reviewing your monthly Explanation of Benefits statements.
The Medicare Prescription Payment Plan: Spreading Costs Into Monthly Installments
Even with a $2,100 cap, paying large drug costs all at once early in the year can be a hardship. If you take an expensive medication and fill it in January, you might owe several hundred dollars at the pharmacy counter before you have built up any progress toward the cap. For beneficiaries on fixed incomes, that kind of front-loaded expense can be difficult to absorb.
The Medicare Prescription Payment Plan, introduced under the Inflation Reduction Act beginning in 2025, solves this problem. It allows you to spread your out-of-pocket Part D drug costs into predictable monthly installments throughout the year. Here is how it works:
- No interest and no credit check: The payment plan is not a loan. There are no finance charges, no application fees, and no credit check. Every Part D enrollee is eligible.
- Opt in at any time: You can enroll in the payment plan at the beginning of the year, mid-year, or whenever you start taking a new expensive medication. Contact your Part D plan directly to opt in.
- Predictable monthly payments: Your plan estimates your total annual out-of-pocket drug costs and divides them into equal monthly payments. Instead of paying $590 at the pharmacy in January for your deductible and then large copays for the next few months, you pay a steady amount each month.
- Automatic recalculation: If your prescriptions change during the year — for example, your doctor adds a new drug or you switch to a generic — your plan recalculates your monthly payment amount. Once you hit the $2,100 cap, your monthly installments adjust accordingly since you no longer owe cost-sharing at the pharmacy.
The payment plan is especially valuable for beneficiaries who take specialty-tier medications with high coinsurance or those who fill expensive prescriptions in the first few months of the year. It turns unpredictable pharmacy bills into a budgetable monthly expense.
Who Benefits Most from the Out-of-Pocket Cap?
The out-of-pocket cap benefits every Part D enrollee by providing financial certainty, but some groups see dramatically larger savings than others. Here is who gains the most.
Beneficiaries Taking Specialty Medications
People who take specialty drugs for conditions like cancer, multiple sclerosis, rheumatoid arthritis, hepatitis C, or HIV see the largest dollar savings. These medications can cost $5,000 to $15,000 per month at list price. Under the old rules, a beneficiary on a $10,000-per-month drug could spend $6,000 or more per year in out-of-pocket costs because the 5% catastrophic coinsurance had no limit. With the $2,100 cap, those same beneficiaries save thousands of dollars annually.
Beneficiaries Taking Multiple Brand-Name Drugs
Even without a single high-cost specialty drug, beneficiaries who take several brand-name medications can accumulate significant out-of-pocket costs over the course of a year. A combination of three or four brand-name drugs with coinsurance rates of 25% to 33% could easily push someone past the old catastrophic threshold. The $2,100 cap ensures that once the limit is reached, all additional prescriptions for the year are free.
Beneficiaries Diagnosed With New Conditions Mid-Year
A cancer diagnosis, an organ transplant, or a new chronic condition can suddenly require expensive medications that were not part of your drug regimen at the start of the year. Before the cap, these unexpected drug costs could be devastating. Now, no matter when in the year a new costly prescription begins, your total out-of-pocket responsibility is capped at $2,100.
Who May See Less Direct Impact
Beneficiaries who only take inexpensive generic medications may never come close to the $2,100 cap in a given year. Their annual drug costs may remain well under the deductible or within the initial coverage phase. However, the cap still provides peace of mind — if their medication needs change, the financial ceiling is in place. Beneficiaries with full Extra Help (Low Income Subsidy) already pay minimal or zero cost-sharing, so the cap functions primarily as a backstop rather than a primary source of savings for them.
How the Cap Interacts With the Donut Hole Elimination
The out-of-pocket cap and the donut hole elimination are two distinct but complementary changes from the Inflation Reduction Act. Together, they fundamentally restructured how Part D costs work.
The donut hole elimination ensures your cost-sharing stays the same when you move from initial coverage into the coverage gap. You pay the same copays and coinsurance in every phase up to the cap — there is no sudden spike in costs when total drug spending crosses $5,030.
The out-of-pocket cap ensures that your total annual spending has a hard ceiling. Even if your drugs are expensive enough to push you through the deductible, initial coverage, and coverage gap quickly, you never pay more than $2,100 in a year.
Before these changes, the coverage gap was the biggest threat to moderate spenders and the 5% catastrophic coinsurance was the biggest threat to high spenders. Now both threats are neutralized. The result is a Part D benefit that behaves more like traditional health insurance with a simple annual out-of-pocket maximum — something beneficiaries and advocates had been requesting since the program began in 2006.
Extra Help and the Low Income Subsidy: Changes for 2026
Extra Help — officially called the Low Income Subsidy (LIS) — is a federal program that helps Medicare beneficiaries with limited income and resources pay for Part D prescription drug costs. The Inflation Reduction Act expanded eligibility for full Extra Help benefits, and these expanded criteria remain in effect for 2026.
Before the IRA, there were two levels of Extra Help: full and partial. Partial Extra Help provided reduced cost-sharing but still required beneficiaries to pay some deductible and copays. The IRA eliminated the partial Extra Help tier for most beneficiaries by raising the income threshold for full Extra Help from 135% to 150% of the federal poverty level. This means people who previously received only partial benefits now qualify for full Extra Help with even lower costs.
To qualify for full Extra Help in 2026, your income must be below approximately $22,590 for an individual or $30,660 for a married couple living together, and your countable resources must be below $17,220 for an individual or $34,360 for a couple. With full Extra Help, you receive:
- $0 or very low monthly premium for Part D plans at or below the benchmark
- $0 annual deductible
- Copays of $0 to $4.50 for generic drugs and $0 to $11.20 for brand-name drugs
- No coverage gap — Extra Help effectively bypasses the donut hole
People who receive full Medicaid, Supplemental Security Income (SSI), or participate in a Medicare Savings Program are automatically enrolled in Extra Help. If you are not automatically enrolled but believe you may qualify, you can apply online at ssa.gov, by calling Social Security at 1-800-772-1213, or through your state's SHIP (State Health Insurance Assistance Program) counselor. There is no penalty for applying and being denied.
Practical Steps to Make the Most of the Cap in 2026
The out-of-pocket cap provides automatic protection, but there are concrete steps you can take to minimize your costs and make the cap work even harder for you.
- Review your Part D plan during Annual Enrollment: Plan formularies, tier placements, and copay structures change every year. A drug that was on a low tier last year may move to a higher tier this year, affecting how quickly you approach the cap. Use the Medicare Plan Finder at Medicare.gov each fall to compare plans based on your specific medications.
- Choose generics whenever possible: Generic drugs cost 80% to 85% less than brand-name equivalents and contain the same active ingredients. Using generics keeps your total spending lower, which may mean you never reach the cap at all — saving you the most money overall.
- Enroll in the Medicare Prescription Payment Plan: If you expect your out-of-pocket costs to be substantial, opt into the payment plan early in the year. This spreads the costs into manageable monthly installments and prevents the financial shock of paying large deductible and copay amounts upfront.
- Use your plan's preferred pharmacy: Filling prescriptions at a preferred pharmacy means lower copays for every fill. Over the course of a year, the savings can be significant — and lower copays mean it takes longer to reach the cap, which means you spend less overall.
- Consider mail-order for maintenance drugs: Many plans offer 90-day supplies at a lower per-day cost through mail-order pharmacies. For medications you take regularly, this can reduce both cost and trips to the pharmacy.
- Apply for Extra Help if your income is limited: If your income is below approximately $22,590 (individual) or $30,660 (couple), you may qualify for Extra Help that reduces your costs to near zero. Many eligible beneficiaries never apply because they do not realize they qualify.
- Track your out-of-pocket spending: Log into your plan's member portal or review your Explanation of Benefits statements to monitor how close you are to the $2,100 cap. Knowing your progress helps you anticipate when your costs will drop to $0 for the remainder of the year.
- Check for negotiated drug prices: The Inflation Reduction Act authorized Medicare to negotiate prices directly with manufacturers for certain high-cost drugs. The first batch of negotiated prices took effect in 2026. If you take one of these drugs, the lower negotiated price means your copays and coinsurance will also be lower, reducing how much counts toward the cap.
2026 Part D Out-of-Pocket Cap at a Glance
Here are the key numbers for Medicare costs in 2026 as they relate to the Part D out-of-pocket cap:
- Annual out-of-pocket cap: $2,100 (up from $2,000 in 2025)
- Maximum annual deductible: $590 (your plan may set a lower amount)
- Initial coverage limit: $5,030 in total drug costs (you + plan combined)
- Cost after reaching the cap: $0 for all covered Part D drugs for the rest of the year
- National base beneficiary premium: Approximately $36.78 per month (actual premium varies by plan)
- Insulin cap: $35 per month for a 30-day supply, regardless of coverage phase
The Bottom Line
The Medicare Part D out-of-pocket cap is the most important financial protection ever added to the prescription drug benefit. For the first time in the program's history, Medicare beneficiaries have a guaranteed maximum on what they can spend on covered drugs each year. Whether you take one expensive specialty medication or a handful of brand-name drugs, the $2,100 cap in 2026 ensures your costs have a hard ceiling.
The $100 increase from $2,000 to $2,100 reflects the annual adjustment built into the Inflation Reduction Act, and while any increase is worth noting, the protection it provides is still transformative compared to the old system where costs were unlimited. Paired with the elimination of the donut hole's financial impact and the removal of the 5% catastrophic coinsurance, the cap creates a Part D benefit structure that is fairer and more predictable than ever before.
To make the most of these protections, review your Part D plan every year during Annual Enrollment. Choose generics when available. Use preferred pharmacies and mail-order options. Consider the Medicare Prescription Payment Plan if your costs are front-loaded. And if your income is limited, apply for Extra Help — it can reduce your drug costs to near zero.
The days of unlimited prescription drug spending in Medicare are over. The out-of-pocket cap is here, it is adjusted annually to remain relevant, and it is the financial backstop that every Part D enrollee now has in their corner. Understanding how it works — and taking advantage of every tool available to reduce your costs — is the best way to protect your health and your budget in 2026 and beyond.
Ready to Find the Right Medicare Plan?
Answer a few quick questions and a licensed agent will help you compare plans — free, no obligation.
Sources
- Medicare.gov -- Drug Coverage (Part D)
- CMS.gov -- Medicare Part D Out-of-Pocket Cost Cap
- CMS.gov -- 2026 Medicare Parts A & B Premiums and Deductibles
- HHS.gov -- Inflation Reduction Act and Medicare
- Medicare.gov -- Medicare Prescription Payment Plan
- SSA.gov -- Extra Help with Medicare Prescription Drug Plan Costs
- Medicare.gov -- Medicare Costs at a Glance
Frequently Asked Questions
What is the Medicare Part D out-of-pocket cap for 2026?
In 2026, the Medicare Part D out-of-pocket cap is $2,100. This is an increase from the initial $2,000 cap that was introduced in 2025 under the Inflation Reduction Act. The cap is adjusted annually based on the rate of per capita Part D spending growth. Once your true out-of-pocket spending on covered Part D prescription drugs reaches $2,100 in a calendar year, you pay $0 for all covered prescriptions for the remainder of that year. The cap resets on January 1 of each new year.
What counts toward the Part D out-of-pocket cap?
Only your true out-of-pocket spending on covered Part D drugs counts toward the $2,100 cap. This includes payments you make for your annual deductible, copayments, and coinsurance on formulary drugs. Monthly Part D premiums do not count. The Part D late enrollment penalty does not count. Spending on drugs that are not on your plan's formulary does not count. If a drug manufacturer provides a discount in the coverage gap phase, that discount does count toward your out-of-pocket total for brand-name drugs.
How does the Medicare Prescription Payment Plan work?
The Medicare Prescription Payment Plan allows you to spread your out-of-pocket Part D drug costs into predictable monthly installments instead of paying large amounts at the pharmacy counter. There is no interest charged, no credit check, and no application fee. You can opt in at any time during the year by contacting your Part D plan. Your plan calculates your estimated annual out-of-pocket costs and divides them into equal monthly payments. If your costs change during the year, such as when you add or drop a medication, your monthly payment amount is recalculated. Once you reach the $2,100 out-of-pocket cap, your remaining installments may be adjusted downward.
Who benefits the most from the out-of-pocket cap?
The beneficiaries who benefit the most are those who take expensive specialty medications or multiple brand-name drugs. Before the cap existed, people taking specialty drugs for conditions like cancer, rheumatoid arthritis, multiple sclerosis, or hepatitis C could spend $5,000, $10,000, or more each year on Part D prescriptions because the old 5% catastrophic coinsurance had no upper limit. The $2,100 cap saves these individuals thousands of dollars annually. Beneficiaries who already qualified for Extra Help (the Low Income Subsidy) generally see less direct impact because their out-of-pocket costs were already minimal, though the cap provides an additional layer of financial protection.
Does the out-of-pocket cap apply to Medicare Advantage plans with drug coverage?
Yes. The $2,100 out-of-pocket cap applies to all Medicare Part D coverage, whether you have a standalone Part D prescription drug plan (PDP) paired with Original Medicare or a Medicare Advantage plan that includes Part D drug coverage (MA-PD). The cap works the same way in both types of plans. Once your true out-of-pocket spending on covered Part D drugs reaches $2,100 in a calendar year, you pay nothing more for covered prescriptions regardless of which type of plan you have.
Can I still get Extra Help if the out-of-pocket cap exists?
Yes. Extra Help (the Low Income Subsidy) and the out-of-pocket cap are separate protections that can work together. Extra Help reduces or eliminates your Part D premiums, deductible, and copayments based on your income and resources. The out-of-pocket cap provides a hard ceiling on your annual drug spending. If you qualify for Extra Help, your out-of-pocket costs will typically be well below the $2,100 cap. However, having the cap in place means that even if your Extra Help level changes or you lose eligibility during the year, you still have a guaranteed maximum. You can apply for Extra Help at ssa.gov, by calling 1-800-772-1213, or through your local State Health Insurance Assistance Program.
Will the out-of-pocket cap amount increase every year?
Yes. The Inflation Reduction Act established that the out-of-pocket cap is adjusted annually based on the rate of growth in per capita Part D drug spending. The initial cap was set at $2,000 for 2025 and increased to $2,100 for 2026. CMS announces the updated cap amount each year alongside other Medicare cost updates, typically in the fall before the new benefit year begins. The adjustment is designed to keep the cap roughly in line with rising drug costs while still providing meaningful financial protection for beneficiaries.
What happens if I switch Part D plans mid-year — does my out-of-pocket spending carry over?
Yes. If you switch Part D plans during the year, any true out-of-pocket spending you accumulated under your previous plan carries over to your new plan and counts toward the $2,100 cap. Your new plan receives this information through CMS coordination records. You do not start over from zero. This ensures that switching plans due to a qualifying event such as moving, losing employer coverage, or gaining Medicaid eligibility does not reset your progress toward the annual cap.
More Medicare Articles
Next Round of Medicare Drug Negotiations: 15 Drugs Selected for 2027
CMS has selected 15 additional Part D drugs for Medicare price negotiation under the Inflation Reduction Act, with new lower prices taking effect in 2027 and saving billions more for beneficiaries.
2026 Medicare Advantage Rule Changes: What Beneficiaries Need to Know
A comprehensive breakdown of the CMS CY2026 Medicare Advantage final rule — covering prior authorization reforms, mid-year benefit restrictions, D-SNP integration, agent compensation changes, network adequacy updates, supplemental benefit guardrails, and star rating methodology shifts — and what each change means for enrollees.
Medicare Part A Costs in 2026: Deductibles, Coinsurance, and Premiums
Every 2026 Medicare Part A cost explained — the $1,676 hospital deductible, daily coinsurance for days 61-90 and lifetime reserve days, skilled nursing facility costs, premiums for those without 40 work quarters, the blood deductible, and how Medigap fills the gaps.
What Medicare Covers for Diabetes: Supplies, Medications, and Prevention
Medicare provides comprehensive diabetes coverage including supplies, medications, self-management training, and prevention programs. Learn what Part B and Part D cover, how the $35 insulin cap works, and how to get continuous glucose monitors through Medicare.